首页> 美国卫生研究院文献>Heliyon >DFT-based reactivity and combined QSAR molecular docking of 1245-Tetrazine derivatives as inhibitors of Pim-1 kinase
【2h】

DFT-based reactivity and combined QSAR molecular docking of 1245-Tetrazine derivatives as inhibitors of Pim-1 kinase

机译:基于DFT的反应性和结合QSAR1245-四嗪衍生物作为Pim-1激酶抑制剂的分子对接

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present work we have calculated several DFT reactivity descriptors for 1,2,4,5-Tetrazine at the B3LYP/6–311++G(d,p) level of theory in order to analyze its reactivity in vacuum and solvent phases. Whereas, the influence of the solvent was taken into account employing the PCM model. DFT-based descriptors such as (electronic chemical potential, electrophilicity, condensed Fukui function….) have been determined to predict the reactivity of 1,2,4,5-Tetrazine. A series of eighteen 1,2,4,5-Tetrazine derivatives was studied by using two computational techniques, namely, quantitative structure activity relationship (QSAR) and molecular docking. QSAR models of the antitumor activity of some 1,2,4,5-Tetrazine derivatives were established in gas and solvent phases which exhibited good statistical values for both cases. Whereas, multiple linear regression (MLR) procedure was used to obtain the best QSAR models and the leave-one-out (LOO) method to estimate the predictivity of our models. The most and the least active compounds were docked with the protein (3C4E) to confirm those obtained results from QSAR models and elucidate the binding mode between this type of compounds and corresponding protein.
机译:在目前的工作中,我们已经计算了B3LYP / 6–311 ++ G(d,p)的1,2,4,5-四嗪的DFT反应性描述子,以分析其在真空和溶剂相中的反应性。而采用PCM模型考虑了溶剂的影响。已经确定了基于DFT的描述子,例如(电子化学势,亲电性,稠合的Fukui函数……)来预测1,2,4,5-Tetrazine的反应性。通过使用两种计算技术,即定量结构活性关系(QSAR)和分子对接,研究了一系列十八种1,2,4,5-四嗪衍生物。建立了一些1,2,4,5-Tetrazine衍生物在气相和溶剂相中的抗肿瘤活性的QSAR模型,这两种情况均显示出良好的统计值。而使用多元线性回归(MLR)程序来获得最佳的QSAR模型,并采用留一法(LOO)方法来估计模型的可预测性。活性最高和最低的化合物与蛋白质(3C4E)对接,以确认从QSAR模型获得的结果,并阐明此类化合物与相应蛋白质之间的结合方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号